SMTI Sanara Gross Profit Rate

SMTI (Sanara MedTech Inc.) - company brandmark

Sanara MedTech Inc. (SMTI) effectively captures the specialized tissue regeneration niche, shielding profitability from dumping. Reviewing the gross margin dynamics on GURU.Markets, the latest parameter stands at 90.70, confirming the sales efficiency of collagen products and dressing materials. Business stability is ensured by the supply of bioproducts to hundreds of US clinics, which minimizes patent risks and dependence on major networks.

Sanara (SMTI) Return on Gross Profit: for the period 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for sanaramedtech.com (SMTI)

- market value and analyst target forecast:
Fundamental valuation:Sanara MedTech
Core merchandise of Sanara MedTech Inc.

To assess the financial stability of Sanara MedTech Inc. (SMTI), investors analyze the gross margin, calculated as the ratio of the difference between revenue and cost of goods sold to total sales. This metric determines the production efficiency of biomaterials, where the optimization of collagen procurement directly impacts the current gross margin, confirming the company's ability to maintain high profitability despite complex logistics costs.